Normal cells in a culture enter a nondividing state after a finite number of population doubling, which is termed replicative senescence, whereas cancer cells have unlimited proliferative potential and are thought to exhibit an immmortal phenotype by escaping from senescence. The p21 gene (also known as sdi1), which encodes the cyclin-dependent kinase inhibitor, is expressed at high levels in senescent cells and contributes to the growth arrest. To examine if the p21 sdi1 gene transfer could induce senescence in human cancer cells, we utilized an adenoviral vector-based expression system and four human cancer cell lines differing in their p53 status. Transient overexpression of p21 sdi1 on cancer cells induced quiescence by arresting the cell cycle at the G 1 phase and exhibited morphological changes, such as enlarged nuclei as well as a flattened cellular shape, specific to the senescence phenotype. We also showed that p21 sdi1 -transduced cancer cells expressed b-galactosidase activity at pH 6.0, which is known to be a marker of senescence. Moreover, the polymerase chain reaction-based assay demonstrated that levels of telomerase activity were significantly lower in p21 sdi1 -expressing cells compared to parental cancer cells. These observations provide the evidence that p21 sdi1 overexpression could induce a senescence-like state and reduce telomerase activity in human cancer cells, suggesting that these novel p21 sdi1 functions may have important implications for anticancer therapy.
Introduction
Normal diploid mammalian cells undergo a finite number of population doubling in culture before they accrue replicative senescence. 1 In contrast, tumors often contain immortalized cells that exhibit an unlimited in vitro and in vivo proliferative potential. These facts suggest that the limited lifespan of normal human cells is a tumor suppressor mechanism and that escape from senescence to yield immortal variants could be an important step in tumorigenesis. 2, 3 Fusion of normal and immortalized cells usually results in hybrids with limited proliferative potential, indicating that immortalization is probably due to the loss of normal gene function. 4 Although studies of the transforming proteins of DNA tumor viruses have indicated the involvement of the p53 gene and the retinoblastoma (Rb) susceptibility gene in senescence, 5 ± 7 molecular analyses have identified more changes in gene expression and in the activity of gene products during cellular aging. Differential screening comparing young and senescent human cells has also revealed differences in the expression of several genes. 2 Noda et al 8 has reported that expression of the sdi1 gene, which encodes a 21 kDa protein product, increases in senescent cells compared with young cells and that the increase parallels the onset of the senescent phenotype, suggesting that p21 sdi1 may be a causal candidate gene for cellular senescence. p21 sdi1 was subsequently cloned as a gene encoding a cyclindependent kinase (Cdk) inhibitor (Cip1), 9 and as a gene transcriptionally activated by p53 (Waf1).
10 p21 sdi1 was also cloned as a melanocyte differentiation-associated factor activated independent of p53 (mda-6). 11 These findings concerning p21 sdi1 have elucidated the potent interactions of cellular senescence, cell cycle regulation, cell differentiation, and tumor suppression, and prompted us to study the effect of ectopic p21 sdi1 gene expression in human cancer cells.
The immortalization of normal human cancer cells is often associated with the reactivation of the enzyme telomerase, which adds TTAGGG hexanucleotide repeats on to the telomeres of chromosomes. Telomerase is thought to be present in germ cells, immortal cell lines and cancer cells, but not in normal somatic cells. Telomeres in normal somatic cells are shorter by approximately 50 base pairs with every cell division. It has been proposed that this progressive decrease in Cell Death and Differentiation (1999) 6, 765 ± 772 telomere length acts as a mechanism for counting cell divisions and that sufficient telomeric shortening triggers senescence. 12 However, telomerase is reactivated in immortal human cancer cells and, moreover, the enzyme activity is detectable in over 80% of human tumor samples. These observations lead to the hypothesis that terminally nondividing cancer cells in the senescence-like state might have decreased levels of telomerase activity.
In the present study, to investigate the biological significance of p21 sdi1 on human cancer cells, p21 sdi1 was exogenously introduced into several cancer cell lines differing in their p53 status by a recombinant adenovirus vector. Our results demonstrate that ectopic p21 sdi1 overexpression induces the cellular senescence accompanied with the specific cell cycle arrest, leading to the downregulation of telomerase activity. These studies may have important implications for developing a novel senescencedirected anti-cancer therapy.
Results
Adenovirally transduced p21 sdi1 gene expression in human cancer cells Four human cancer cell lines of different tissue origin were examined for the effects of p21 sdi1 expression: H1299 (lung) and Saos-2 (osteosarcoma) with deleted p53, DLD-1 (colon) with mutated p53, and LoVo (colon) with wild-type p53. We employed a replication-deficient adenovirus vector system for the p21 sdi1 gene transfer. Western blot analysis demonstrated that readily detectable p21 sdi1 protein expression was achieved in all cell lines as early as 24 h after AdCMVp21 infection at a multiplicity of infection (MOI) of 50, whereas parental and AdRSVLuc-infected cells exhibited no detectable p21 sdi1 protein ( Figure 1) . A time-course experiment showed that p21 sdi1 expression was detectable over a period of 15 days after AdCMVp21 infection.
Effect of p21
sdi1 expression on growth and cell-cycle progression of human cancer cell lines
We looked next for the effect of p21 sdi1 overexpression on the growth of human lung cancer cells. H1299 cells which remained as an attached monolayer were assessed for viability by measuring trypan blue uptake for 6 days following infection with AdCMVp21 and AdRSVLuc at 50 MOI for 24 h. As shown in Figure 2A , AdCMVp21 markedly suppressed the growth rate of H1299 cells and induced the growth arrest as long as we observed, while AdRSVLuc did not affect the cell growth. This inhibitory effect of transduced p21 sdi1 on human cancer cells is consistent with previous reports. 13 ± 15 To investigate the mechanism of p21 sdi1 -mediated growth suppression, we performed the cell cycle analysis on H1299, DLD-1, and LoVo cells. Cells were infected with either AdCMVp21 or AdRSVLuc, harvested at 48 h postinfection, and then assayed for DNA contents by flow cytometry. AdCMVp21-infected cells showed a decreased fraction of S-phase cells resulting from an accumulation of most cells in the G 0 /G 1 phase, suggesting arrest predominantly at the G 1 checkpoint ( Figure 2B ). We also examined the cell cycle distribution of Saos-2 cells, which did not show a typical diploidy pattern. The fraction equivalent for the S-and G 2 /M phase decreased and, in contrast, that for the G 0 /G 1 phase increased, indicating that progression into S-phase was blocked in Saos-2 cells (data not shown).
Morphologic effects and SA-b gal expression in human cancer cells transduced with p21 sdi1 gene
Alterations in cell morphology were also studied after AdCMVp21 infection. p21 sdi1 -transduced H1299 cells showed morphological changes 3 days after infection, such as an enlarged, flattened shape, an increased cytoplasmic-to nuclear ratio, and a decreased cell density, consistent with a senescence phenotype. Identical results were obtained with other cell lines: DLD-1, LoVo, and Saos-2.
To further examine whether the morphological changes indicated cellular senescence, we assessed SA-b-gal activities in four cell lines. SA-b-gal activity at pH 6.0, which is a specific biomarker for senescent cells, are not expressed in presenescent and quiescent cells. 16 Most AdCMVp21-transduced cells processing the senescent morphology expressed intense SA-b-gal activity as early as 2 days after infection. In contrast, little or no SA-b-gal activities were detected in untreated or AdRSVLuc-infected cells. The micrographs of each cell line exhibiting the characteristic morphology and SA-b-gal staining were illustrated in Figure 3A . These results revealed that AdCMVp21 infection induced a senescence-like state in human cancer cells.
We next examined whether withdrawal from the cell cycle by serum deprivation could cause alterations in cell morphology. Although the growth of H1299 and DLD-1 cells cultured in the absence of serum was significantly reduced as evidenced by a decreased cell density, cells exhibited neither a flattened morphology nor enlarged nuclei ( Figure  3B ). Similar results were obtained with Saos-2 and LoVo cells (data not shown). Thus, the morphologically altered phenotype, indicative of the senescence-like state, appeared not to be due to the withdrawal from the cell cycle.
McConnell et al 17 have reported that plasminogen activator inhibitor (PAI-1) mRNA expression is up- 
Effect of p21 sdi1 overexpression on telomerase activity
Progressive loss of telomeres in normal cells has been thought to activate sensing mechanisms responsible for cellular senescence. Therefore, we hypothesized that induction of senescence by p21 sdi1 expression might be associated with a pronounced downregulation of telomerase activity. We assessed telomerase activities of p21 sdi1 -transduced human cancer cells by using a recently developed PCR-based TRAP assay. 18, 19 AdCMVp21 infection reduced the relative telomerase levels in H1299, DLD-1, and LoVo cells at 72 h of post-transduction; the level of telomerase activity did not change upon AdRSVLuc control vector infection ( Figure 5A ). Although, in the case of Saos-2 cells, the telomerase level was quite low, the reduction in telomerase activity was observed.
In accordance with the morphological analysis, H1299 and DLD-1 cells cultured in the absence of serum exhibited similar telomerase levels, despite significant growth inhibition when serum was withdrawn ( Figure 5B ). These results suggest that quiescent tumor cells could retain telomerase activity and that downregulation of telomerase activity might be a direct effect of p21 sdi1 gene transfer.
Discussion
The present study demonstrates that overexpressed p21 sdi1 arrests human cancer cell growth by blocking cell-cycle progression and induces the senescence-like state, as evidenced by cell morphology, which is similar to that commonly observed with senescent fibroblasts, as well as positive SA-b gal staining, which is histochemically detectable at pH 6.0 upon senescence. We utilized an adenoviral vector system, which is applicable for various cell types with different tissue origin, to introduce the ectopic p21 sdi1 gene into human cancer cells. Our results demonstrated that the expression of the adenovirally transduced p21 sdi1 gene was sufficient to exhibit its biological functions. In addition, our preliminary experiments confirmed that levels of adenovirus-mediated recombinant p21 sdi1 protein expression varied among cell types; those levels, however, did not exceed physiological levels. Thus, our p21 sdi1 expression system may be relevant for studying the cellular responses related to p21 sdi1 . Many studies comparing young and senescent human cells have attempted to identify molecular mechanisms leading to the induction of the senescence phenotype. Genes that have been implicated in regulating senescence include tumor suppressor genes such as p53 and Rb, 4, 20, 21 Cdk inhibitors such as p21 sdi18 and p16, 22 ± 24 and several currently unidentified genes. Recent studies have shown that ectopic p16 expression induces senescence on human fibroblasts as well as human cancer cells; induction of senescence by p21 sdi1 , however, has been reported only in fibroblasts. 17,25 ± 27 Overexpression of the wild-type p53 gene has demonstrated to trigger a rapid senescence program in human bladder carcinoma cells containing a mutant form of p53. 20 Growth arrest as well as morphological changes accompanied with activation of SA-b gal activity were induced by an exogenously expressed p53 gene in the teracyclin-inducible expression system. These p53-mediated cellular responses are very similar to those that we observed by p21 sdi1 introduction. Together with the fact that p53 is a direct upstream regulator of p21 sdi1 , p21 sdi1 rather than p53 may be thought to play an important role in the cell senescence phenomenon of human cancer cells. We previously reported that adenovirus-mediated transfer of the wild-type p53 gene into p53-deficient H1299 human lunc cancer cells induced apoptotic cell death and resulted in the rapid decrease of cell viability despite endogenous p21 sdi1 expression; 28 our results described here, however, demonstrated that p21 sdi1 overexpression triggered a senescence program without apoptosis induction. Thus, p53 can induce senescence through p21 sdi1 in some types of cancer cells and may initiate the apoptotic control machinery by direct signaling that can overcome the p21 sdi1 functions in other types of cells.
Recently, it has been reported that expression of oncogenic ras triggered senescence in primary human or rodent fibroblasts, which was associated with increases in p53, p21 sdi1 , and p16 levels. 29 Moreover, histon deacetylase inhibitors, sodium butyrate and trichostatin A, induced a senescence-like state in human fibroblast accompanied by increased expression of p21 sdi1 . 30, 31 The finding that butyrate induced p21 sdi1 expression by the activation of its promoter 32 provided additional evidence that p21 sdi1 might participate in the induction of senescence. The observation that expression of a number of genes has been altered during cellular aging brings up the questions of which changes in gene expression cause cellular senescence and which result from the senescence phenotype. Our gene transfer experiments demonstrated that at least human cancer cells transduced with the ectopic p21 sdi1 gene underwent senescence, suggesting that p21 sdi1 expression may not be the result of other mechanisms causing senescence. In addition, whether the changes to senescence features, such as morphological changes and the reduction of telomerase activity, is due to senescence induction or is merely accompanied with the cell-cycle arrest was elucidated. We confirmed that cell cycle arrest induced by serum depletion could not induce any changes indicative of senescence. p21 sdi1 is known to inhibit the activities of cyclin-Cdk complexes, thereby preventing phosphorylation of the Rb protein, and was initially characterized as an inhibitor of the cell cycle. When phosphorylated, the Rb protein can no longer sequester the transcriptional factors of the E2F family, which in turn regulates many genes required to initiate the S-phase of the cell cycle. Although these cell cycle regulatory mechanisms have been identified recently, the resultant events mediated by p21 sdi1 for senescence induction is presently unclear. Our study has indicated that p21 sdi1 activated a commitment to the progression of a senescence program even in Saos-2 human osteosarcoma cells with homozygously deleted p53 and Rb genes. It has been reported that p21 sdi1 could inhibit E2F activity by direct means in cells lacking a functional Rb protein, 33 suggesting that the Rb protein is not essential for E2F-dependent transcription and that p21 sdi1 may directly act on E2F activity in Saos-2 cells.
The role of telomeric attrition in p21 sdi1 -mediated senescence was studied in our model, because telomere removal might result in replicate senescence. Our results indicate that cells showing the senescence phenotype following the p21 sdi1 gene transfer expressed quite low levels of telomerase activity. We and others 34, 35 have demonstrated that although telomerase activity is regulated in the cell cycle-dependent manner, withdrawal from the cell cycle alone does not inhibit its activity, suggesting that p21 sdi1 -mediated G1 arrest is not the cause of antitelomerase effect. Several reports have shown that telomerase activity is downregulated during differentiation in some cell types. 36 
Materials and Methods

Cells and culture conditions
The following cell lines were used: a human non-small cell lung cancer cell line H1299, which has homozygously deleted p53; a human colon carcinoma cell line DLD-1, which exhibits a homozygous p53 gene mutation; and a human colon carcinoma cell line LoVo, which contains wild-type p53. 42 These cells were routinely propagated in monolayer culture in RPMI 1640 medium supplemented with 10% fetal calf serum, 25 mM HEPES, 100 units/ml penicillin, and 100 mg/ml streptomycin. The human osteosarcoma cell line Saos-2, which has homozygously deleted p53 and Rb, was grown in monolayer culture in Dulbecco'smodified Eagle's Medium (D-MEM) (Gibco, Grand Island, NY, USA) with low glucose supplemented with 10% fetal calf serum, 25 mM HEPES, 100 units/ml penicillin, and 100 mg/ml streptomycin. The transformed embryonic kidney cell line 293 was grown in D-MEM with high glucose (4.5 g/l), supplemented with 10% fetal calf serum, 100 units/ml penicillin, and 100 mg/ml streptomycin. The 293 cells were used for the production of adenovirus vectors.
Recombinant adenoviruses
The recombinant adenoviral vector expressing human p21 sdi1 gene was previously constructed and characterized. 28, 43 Briefly, the plasmid containing the cytomegalovirus promoter, the wild-type human p21 sdi1 cDNA, and the SV40 polyadenylation signal was cotransfected with pJM17 into 293 cells by liposome/DNA coprecipitation to generate an adenoviral p21 sdi1 expression vector. The resultant virus was named AdCMVp21. An adenoviral vector containing luciferase cDNA (AdRSVLuc) was used as a control vector. Culture supernatant of the viral stocks were quantified by a plaque-forming assay using 293 cells. The viruses were stored at 7808C.
Western blot analysis
Cells were collected by trypsinization and washed twice in cold phosphate-buffered saline (PBS). Cells were then lysed in SDS solubilization buffer (62.5 mM Tris-HCl, pH 6.8, containing 10% glycerol, 5% b-mercaptoethanol, and 2% SDS; Sigma, St. Louis, MO, USA). Equal amounts of proteins were boiled for 5 min and electrophoresed under reducing conditions on a 12.5% (w/v) polyacrylamide gel. Proteins were electrophoretically transferred to a Hybond-polyvinylidence difluoride (PVDF) transfer membrane (Amersham, Arlington Heights, IL, USA), and incubated with primary antibody against p21/WAF1 (Ab-1) (Oncogene Science, Manhasset, NY, USA), PAI-1 (Ab-1) (Calbiochem, Cambridge, MA, USA) and actin (Amersham) followed by a peroxidase-linked secondary antibody. An Amersham ECL chemiluminescent Western system (Amersham) was used to detect secondary probes.
Flow cytometric analysis
Trypsinized cells were collected, washed twice with cold PBS, and resuspended in PBS containing 0.1% Triton X-100 and 1 g/l RNase for 5 min at room temperature. Samples were then stained with propidium iodide at 50 mg/ml and analyzed in a cell sorter (FACScan, Becton Dickinson, Mountain View, CA, USA) for DNA content. Cell debris and fixation artifacts were gated out, and G 1 , S, and G 2 /M populations were quantified using the ModFit LT program for Mac Ver. 1.01 (Verity Software House, Inc.).
Senescence-associated b-galactosidase (SA-b-gal) staining
Senescence-associated b-galactosidase (SA-b-gal) was detected as previously described with slight modifications. 16 Cells were washed once with PBS, fixed for 15 min at 48C in 2% formaldehyde/0.2% glutaraldehyde, washed four times and incubated with SA-b-gal staining solution: 1 mg of 5-bromo-4-chloro-3-indolyl b-D-galactosidase (X-Gal) per ml/40 mM sodium phosphate, pH 6.0/5 mM potassium ferrocyanide/5 mM potassium ferricyanide/150 mM NaCl/ 2 mM MgCl 2 overnight at 378C without CO 2 .
Telomerase assays
Telomerase assays were assayed by the PCR-based telomeric repeat amplification protocol 18, 19 using a TRAP-eze telomerase detection kit (Oncor, Gaithersburg, MD, USA) according to the manufacturer's protocol. Cellular extracts from H1299, DLD-1, and LoVo were diluted to 100 ng/ml, and those from Saos-2 were diluted to 750 ng/ml. Two ml of each cellular extracts were subjected to TRAP assay using [g-32 P] dATP (4500 Ci/mmol; ICN, Costa mesa, CA, USA). After the TRAP reaction, samples were loaded on 10% polyacrylamid gel, and those products were visualized by PhosphoImager (Molecular Dynamics, Sunnyvale, CA, USA) or SYBR Green I staining (Molecular Probes, Eugene, OR, USA). Radioactive signal was quantitated using ImageQuant software (Molecular Dynamics) and the relative intensity was calculated as a ratio of TRAP product bands to an internal control band. These values were expressed in terms relative ratio in untreated control cells, which was arbitrarily set at 1 ( Figure 5A, lower panel) .
